{"entity":{"type":"insider","cik":"0001685640","url":"/insider/0001685640","json_url":"/insider/0001685640.json","name":"Plovanic William J.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":3,"first":"2018-03-15","last":"2019-11-14","span_basis":"filed_date"},"name_variants":[{"name":"Plovanic William J.","source":"filing","n_filings":3,"first_seen":"2018-03-15","last_seen":"2019-11-14"}],"transactions":[{"id":7892509,"accession":"0001214659-19-007137","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-19-007137","line_url":"/filing/0001214659-19-007137#line-1","is_derivative":false,"issuer_cik":"0001427570","issuer_name":"OBALON THERAPEUTICS INC","issuer_ticker":"OBLN","issuer_name_source":null,"issuer_url":"/issuer/0001427570","owner_cik":"0001685640","owner_name":"Plovanic William J.","owner_url":"/insider/0001685640","role":"Director, Officer (President & CEO)","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65000.0,"shares_display":"65,000","price_per_share":1.6588,"price_display":"1.66","price_state":"stated","total_value":107822.0,"total_display":"107,822.00","shares_owned_after":106806.0,"shares_owned_after_display":"106,806","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-12","filed_date":"2019-11-14","scope":"insider"},{"id":8249344,"accession":"0001214659-19-005088","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-19-005088","line_url":"/filing/0001214659-19-005088#line-1","is_derivative":false,"issuer_cik":"0001427570","issuer_name":"OBALON THERAPEUTICS INC","issuer_ticker":"OBLN","issuer_name_source":null,"issuer_url":"/issuer/0001427570","owner_cik":"0001685640","owner_name":"Plovanic William J.","owner_url":"/insider/0001685640","role":"Director, Officer (President & CFO)","officer_title":"President & CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12500.0,"shares_display":"12,500","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":50000.0,"total_display":"50,000.00","shares_owned_after":41806.0,"shares_owned_after_display":"41,806","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-06","filed_date":"2019-08-08","scope":"insider"},{"id":6525073,"accession":"0001214659-18-002171","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001214659-18-002171","line_url":"/filing/0001214659-18-002171#line-4","is_derivative":false,"issuer_cik":"0001427570","issuer_name":"OBALON THERAPEUTICS INC","issuer_ticker":"OBLN","issuer_name_source":null,"issuer_url":"/issuer/0001427570","owner_cik":"0001685640","owner_name":"Plovanic William J.","owner_url":"/insider/0001685640","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5412.0,"shares_display":"5,412","price_per_share":4.036,"price_display":"4.04","price_state":"stated","total_value":21842.832,"total_display":"21,842.83","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-14","filed_date":"2018-03-15","scope":"insider"},{"id":6525070,"accession":"0001214659-18-002171","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001214659-18-002171","line_url":"/filing/0001214659-18-002171#line-3","is_derivative":false,"issuer_cik":"0001427570","issuer_name":"OBALON THERAPEUTICS INC","issuer_ticker":"OBLN","issuer_name_source":null,"issuer_url":"/issuer/0001427570","owner_cik":"0001685640","owner_name":"Plovanic William J.","owner_url":"/insider/0001685640","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5300.0,"shares_display":"5,300","price_per_share":4.0352,"price_display":"4.04","price_state":"stated","total_value":21386.56,"total_display":"21,386.56","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-14","filed_date":"2018-03-15","scope":"insider"},{"id":6525067,"accession":"0001214659-18-002171","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-18-002171","line_url":"/filing/0001214659-18-002171#line-2","is_derivative":false,"issuer_cik":"0001427570","issuer_name":"OBALON THERAPEUTICS INC","issuer_ticker":"OBLN","issuer_name_source":null,"issuer_url":"/issuer/0001427570","owner_cik":"0001685640","owner_name":"Plovanic William J.","owner_url":"/insider/0001685640","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9700.0,"shares_display":"9,700","price_per_share":4.0491,"price_display":"4.05","price_state":"stated","total_value":39276.27,"total_display":"39,276.27","shares_owned_after":9700.0,"shares_owned_after_display":"9,700","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-13","filed_date":"2018-03-15","scope":"insider"},{"id":6525064,"accession":"0001214659-18-002171","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-18-002171","line_url":"/filing/0001214659-18-002171#line-1","is_derivative":false,"issuer_cik":"0001427570","issuer_name":"OBALON THERAPEUTICS INC","issuer_ticker":"OBLN","issuer_name_source":null,"issuer_url":"/issuer/0001427570","owner_cik":"0001685640","owner_name":"Plovanic William J.","owner_url":"/insider/0001685640","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9588.0,"shares_display":"9,588","price_per_share":4.0493,"price_display":"4.05","price_state":"stated","total_value":38824.6884,"total_display":"38,824.69","shares_owned_after":9588.0,"shares_owned_after_display":"9,588","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-13","filed_date":"2018-03-15","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001427570","name":"OBALON THERAPEUTICS INC","url":"/issuer/0001427570","role":"Director, Officer (President & CEO)","n_filings":3,"first_seen":"2018-03-15","last_seen":"2019-11-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001685640","retrieved_at":"2026-08-20T17:05:19+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}